Articles
Page 18 of 19
-
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P288
-
Impact of hyperglycemia and cholesterol levels on the outcome of hepatitis C treatment in HIV/HCV co-infected patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P274 -
Is prognosis after first AIDS-defining pathology incidence becoming better in recent years of HAART era?
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P251 -
An open-label multicentre pilot study evaluating the pharmacokinetics (PK) of co-administered lopinavir (LPV) and nevirapine (NVP) in HIV+ adults
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P250 -
Modelling the change in lopinavir apparent oral clearance over time following cessation of lopinavir/ritonavir: data from the TAIL study
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P241 -
D-dimer and anti-coagulation activity markers in children and adolescents with HIV infection
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P213 -
Estimating renal impairment and evaluating antiretroviral dose adjustments among HIV-positive patients: a comparison of three hospitals
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P204 -
Impact of HIV viral diversity and baseline resistance on treatment outcomes and the emergence of resistance: the CASTLE study 48-week results
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P180 -
Quantitative and qualitative mtDNA-lesions with mitochondrial dysfunction in multiple organs after HAART-associated fatal lactacidosis
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P145 -
"Endocrine NAFLD": a hormonocentric perspective of Non-Alcoholic Liver Disease (NAFLD) pathogenesis in HIV-infected patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P140 -
Statistical agreement between ultrasound (US) and computerized tomography (CT) for non-alcoholic liver disease (NAFLD) diagnosis
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P139 -
Risk factors for end-stage liver disease among HIV and hepatitis C virus co-infected patients in the Spanish VACH Cohort
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P134 -
Metabolic evaluation of Study M05-730: LPV/r tablets QD vs. BID, co-administered with tenofovir DF + emtricitabine in ARV-naïve HIV-1 infected subjects
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P110 -
Carotid intima media thickness with no cardiovascular disease in HIV-infected patients correlates with a hyperactivated/pro-apoptotic T-cell phenotype
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P97 -
Efficacy and safety of tenofovir/emtricitabine compared to abacavir/lamivudine in HIV-1 infected patients in clinical setting. The TEAL study
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P79 -
Long-term efficacy of boosted and unboosted atazanavir-containing regimens: results from the SCOLTA Project
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P74 -
Simplification from TPV/RTV 500/200 BID to TPV/RTV 500/100 BID guided by therapeutic drug monitoring
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P66 -
48-week outcomes following switch from AZT/3TC to FTC/TDF (TVD) vs. continuing on AZT/3TC: 48-week interim analysis of the RECOMB trial
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P54 -
Efficacy, safety and tolerability of enfuvirtide in a population of Portuguese HIV-1 chronically infected patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P51 -
O415 Efficacy and safety of 48-week maintenance with QD ATV vs ATV/r (both + 2NRTIs) in patients with VL <50 c/mL after induction with ATV/r + 2NRTIs: study AI424136
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O42 -
O414 48-week data from Study AVX-201 – a randomised phase IIb study of apricitabine in treatment-experienced patients with M184V and NRTI resistance
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O41 -
O413 Pharmacokinetics (PK) of once-daily etravirine (ETR) without and with once-daily darunavir/ritonavir (DRV/r) in antiretroviral-naïve HIV-1 infected adults
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O40 -
O412 Factors associated with poor clinical outcome among HIV-infected patients with tuberculosis (TB) in Europe and Argentina. The HIV/TB collaborative study
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O39 -
O332 Opportunistic infections in immunocompromised but virologically suppressed HIV-1 infected patients
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O36 -
O314 Predicting the short-term risk of diabetes in HIV-infected patients in the D:A:D cohort: the D:A:D study group
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O30 -
O313 Relation between adverse effects of ARV treatment and underlying risk in number needed to treat to harm (NNTH) – myocardial infarction and abacavir use
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O29 -
O222 Treatment interruption in children with chronic HIV-infection: the results of the paediatric European network for treatment of AIDS (PENTA) 11 trial
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O21 -
Efficacy and safety by baseline HIV-RNA and CD4 count in treatment-naive patients treated With atazanavir/r and lopinavir/r in the CASTLE study
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P8 -
O123 To overdose or underdose? The question of Kaletra in children in the UK/Irish Collaborative HIV Paediatric Study (CHIPS)
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):O8 -
Efficacy and safety of TMC278 in treatment-naïve, HIV-infected patients: week 96 data from TMC278-C204
Citation: Journal of the International AIDS Society 2008 11(Suppl 1):P2 -
Confronting TB/HIV in the era of increasing anti-TB drug resistance
HIV associated TB is a major public health problem. In 2006, it was estimated that there were over 700,000 people who suffered from HIV associated TB, of whom about 200, 000 have died. The burden of HIV associ...
Citation: Journal of the International AIDS Society 2008 11:6 -
HIV prevention: What have we learned from community experiences in concentrated epidemics?
Drawing on lessons learned from community experiences in concentrated epidemics, this paper explores three imperatives in the effort to reduce the sexual transmission of HIV: combat prevention fatigue, diversi...
Citation: Journal of the International AIDS Society 2008 11:5 -
Prevention of the sexual transmission of HIV-1: preparing for success
There are four opportunities for HIV prevention: before exposure, at the moment of exposure, immediately after exposure, and as secondary prevention focused on infected subjects. Until recently, most resources...
Citation: Journal of the International AIDS Society 2008 11:4 -
HIV/AIDS, conflict and security in Africa: rethinking relationships
The effect of conflict on HIV transmission and regional and global security has been the subject of much recent discussion and debate. Many long held assumptions regarding these relationships are being reconsi...
Citation: Journal of the International AIDS Society 2008 11:3 -
Benefits of an educational program for journalists on media coverage of HIV/AIDS in developing countries
a) To assess the suitability of the curriculum content and didactical quality of information delivered to educate journalists in the J2J program in HIV/AIDS (process evaluation) and b) to explore the effects o...
Citation: Journal of the International AIDS Society 2008 11:2 -
Journal of the International AIDS Society: an important step forward
This editorial welcomes readers to the launch of Journal of the International AIDS society.
Citation: Journal of the International AIDS Society 2008 11:1 -
Effectiveness and Safety of Generic Fixed-Dose Combination of Tenofovir/Emtricitabine/Efavirenz in HIV-1-Infected Patients in Western India
To assess effectiveness and safety of a generic fixed-dose combination of tenofovir (TDF)/emtricitabine (FTC)/efavirenz (EFV) among HIV-1-infected patients in Western India.
Citation: Journal of the International AIDS Society 2008 10:196 -
HIV/AIDS-Related Knowledge Among Malaysian Young Adults: Findings From a Nationwide Survey
HIV/AIDS poses a serious threat to young people, both in Malaysia and throughout the world. A nationwide cross-sectional survey was conducted to assess the knowledge, attitudes, and beliefs about HIV/AIDS amon...
Citation: Journal of the International AIDS Society 2008 10:148 -
Determinants of Treatment Access in a Population-based Cohort of HIV-positive Men and Women Living in Argentina
To report emerging data on the use of highly active antiretroviral therapy (HAART) in Argentina by assessing patterns of HAART access and late vs early treatment initiation in a population-based cohort of adul...
Citation: Journal of the International AIDS Society 2008 10:78 -
Poor Efficacy and Tolerability of Stavudine, Didanosine, and Efavirenz-based Regimen in Treatment-Naive Patients in Senegal
To study the effectiveness and tolerance of an antiretroviral therapy (ART) regimen composed of the antiretroviral agents (ARVs) stavudine (d4T) plus didanosine (ddI) plus efavirenz (EFV) in patients with adva...
Citation: Journal of the International AIDS Society 2007 9:7 -
Tuberculosis and HIV–Needed: A New Paradigm for the Control and Management of Linked Epidemics
Citation: Journal of the International AIDS Society 2007 9:62 -
The 16th International Conference on AIDS: Will It Leave a Legacy?
Citation: Journal of the International AIDS Society 2007 9:15 -
A Process and Outcomes Evaluation of the International AIDS Conference: Who Attends? Who Benefits Most?
The objective of the study was to conduct a process and outcomes evaluation of the International AIDS Conference (IAC). Reaction evaluation data are presented from a delegate survey distributed at the 2004 IAC...
Citation: Journal of the International AIDS Society 2007 9:6 -
Can Urine Lamivudine Be Used to Monitor Antiretroviral Treatment Adherence?
Patient adherence to treatment is an important factor in the effectiveness of antiretroviral regimens. Adherence to treatment could be monitored by estimation of antiretroviral drugs in biological fluids. We a...
Citation: Journal of the International AIDS Society 2006 8:53 -
A Comparative Study of HIV/AIDS: The Knowledge, Attitudes, and Risk Behaviors of Schizophrenic and Diabetic Patients in Regard to HIV/AIDS in Nigeria
Studies on knowledge and risk behaviors related to HIV/AIDS reported from developed countries have shown that people with psychiatric disorders constitute a special risk group. In Nigeria, although similar stu...
Citation: Journal of the International AIDS Society 2006 8:42 -
Understanding the Scourge of HIV/AIDS in Sub-Saharan Africa
Sub-Saharan Africa is the part of the world that has been hit hardest by the HIV epidemic. To fight the spread of HIV in the continent, it is necessary to know and effectively address the factors that drive th...
Citation: Journal of the International AIDS Society 2006 1:30 -
Brief Communication: Economic Comparison of Opportunistic Infection Management With Antiretroviral Treatment in People Living With HIV/AIDS Presenting at an NGO Clinic in Bangalore, India
Highly active antiretroviral treatment (HAART) usage in India is escalating. With the government of India launching the free HAART rollout as part of the "3 by 5" initiative, many people living with HIV/AIDS (...
Citation: Journal of the International AIDS Society 2006 8:24 -
A Population-Based and Longitudinal Study of Sexual Behavior and Multidrug-Resistant HIV Among Patients in Clinical Care
Population-based and longitudinal information regarding sexual risk behavior among patients with multidrug resistant (MDR) HIV and their sexual partners is of great public health and clinical importance.
Citation: Journal of the International AIDS Society 2006 8:72 -
Efficacy, Safety and Pharmacokinetics of Once-Daily Saquinavir Soft-Gelatin Capsule/Ritonavir in Antiretroviral-Naive, HIV-Infected Patients
Once-daily HIV treatment regimens are being used in clinical practice with the objective of improving patient acceptance and adherence.
Citation: Journal of the International AIDS Society 2006 8:36 -
Outcome of Different Nevirapine Administration Strategies in Preventin g Mother-to-Child Transmission (PMTCT) Programs in Tanzania and Uganda
Prevention-of-mother-to-child transmission (PMTCT) interventions based on single-dose nevirapine (NVP) are widely implemented in Africa, but strategies differ regarding how and when to administer the drug to w...
Citation: Journal of the International AIDS Society 2006 8:12